The PwC rebranding includes a refreshed color palette, typography, and key leadership changes to enhance PwC's global ...

The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...

While the rates and timings of tariffs on the sector are unclear, analysts expect that companies will have to absorb any near ...

The $260 million pledge to build 12 technical colleges for high school students is a move towards teaching skills rather than pushing students into university. The report published on Tuesday ...

The best LED strip lights can truly transform any space, softly illuminating any area, be it your office, desk, or kitchen. If you really want to make an impact, RGB lights can enhance your gaming ...

The medications were cited for CGMP deviations, which means the company failed to comply with the FDA's regulations for manufacturing practices, affecting the quality and safety of ... including heart ...

The stock has been trading about 63% below its all-time high. Pfizer's stock price is way down, but the quarterly dividend it pays has risen for 16 consecutive years. At its beaten-down price ...

On April 14, Pfizer announced it would discontinue development of an experimental weight-management pill. Pfizer is facing patent expirations for several of its biggest revenue streams.

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $23.00. The company’s shares closed yesterday at $22.12.